189 filings
Page 7 of 10
6-K
9sfh323
6 Jul 18
Current report (foreign)
4:37pm
EFFECT
gsbjm7v
8 Jun 18
Notice of effectiveness
12:00am
6-K
ktv4q85tgd
7 Jun 18
Invitation to the Ordinary Shareholders' Meeting
4:06pm
CORRESP
g8ot24 g79
6 Jun 18
Correspondence with SEC
12:00am
F-3/A
98a7 7wkry
25 May 18
Shelf registration (foreign) (amended)
6:31am
CORRESP
magvyw u5e094ugkl
25 May 18
Correspondence with SEC
12:00am
UPLOAD
xp6x awqe636z3
17 May 18
Letter from SEC
12:00am
F-3
co3wmmtmb 19v7p
4 May 18
Shelf registration (foreign)
5:25pm
6-K
wguumvg0
2 May 18
Current report (foreign)
6:00am
6-K
royf3bzm5h
27 Apr 18
Current report (foreign)
4:43pm
6-K
4f3kqdraplq7ij58wg86
26 Mar 18
Current report (foreign)
12:00am
6-K
0mqz98j8ytr729c64ks
22 Mar 18
Invitation to the Extraordinary Shareholders' Meeting
12:00am
6-K
cs7gii4
20 Mar 18
AC Immune reports full-year 2017 financial results – successful first year as a public company
12:00am
6-K
fw3w tvv9lsb
13 Nov 17
Current report (foreign)
12:00am
6-K
ggugi36
2 Nov 17
AC Immune to Receive Milestone Payment for Anti-Tau Antibody Moving into Phase 2 Trial for Alzheimer’s Disease
12:00am
6-K
dd9lu4
9 Aug 17
Current report (foreign)
12:00am
6-K
fcysew502u 36u1o6
28 Jun 17
Current report (foreign)
12:00am
6-K
xx4ho2 l8vkey9ys6vco
1 Jun 17
Invitation to the Ordinary Shareholders' Meeting
12:00am
6-K
jgg6sgv
11 May 17
Current report (foreign)
12:00am